PRLog - May 23, 2014 - POMPANO BEACH, Fla. -- Media Contact:
O2 Media, Inc.
The Balancing Act® Airing on Lifetime Helps Women Understand Connection Between AFib and Stroke Risk
Boehringer Ingelheim Pharmaceuticals, Inc. Sponsors Segment on May 26th Show to Help Women Understand AFib; Signs, Symptoms, Risk Factors, Including Stroke
(POMPANO BEACH, Fla. – PR LOG – May 23, 2014) Award-winning morning show The Balancing Act®, airing on the Lifetime® Channel, will feature a segment sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. to clear up misconceptions about the link between atrial fibrillation, the most common kind of irregular heartbeat, and stroke risk. The segment airs Monday, May 26th and again on June 2nd at 7:00 a.m. (ET/PT). Make sure to tune in as The Balancing Act hosts help jump start the day with animated conversation and trusted information to empower a woman’s life.
Don’t miss this featured segment taking center stage on The Balancing Act:
Helping Women Understand AFib and Stroke Risk Brought to You by Boehringer Ingelheim
Atrial Fibrillation (AFib) is a serious heart condition affecting more than five million Americans. AF often remains undiagnosed and untreated. This is a serious concern since AFib carries considerable morbidity and mortality. Among the more devastating complications is the risk of stroke, which AFib patients are at five time greater risk of developing. In fact, every hour, 15 people will suffer a stroke caused by AFib. So what can be done? Joining us to discuss the misconceptions, risk factors, signs, symptoms and the role of anticoagulation in stroke prevention are Dr. Annabelle Volgman from Rush University Medical Center, and guests.
About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates and more than 47,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine. For more information please visit http://us.boehringer-
About The Balancing Act® airing on Lifetime Television
Now in its 6th year, The Balancing Act® continues to empower women in all aspects of their lives. The mission at The Balancing Act is simple - the show strives to help today’s modern woman balance it all by bringing them exceptional solutions to everyday problems. Entertaining, educational and trusted by women, viewers can tune in to America’s premier morning show The Balancing Act on weekday mornings at 7:00 am(ET/PT) airing on Lifetime television. For additional information or to view a segment visit: www.thebalancingact.com
For more information regarding O2 Media Inc. Branded Entertainment, Product Placement and TV Brand Integration go to: http://o2mediainc.com/
Join the Conversation!
Like us on Facebook (https://www.facebook.com/
Follow us on Twitter (http://twitter.com/#!/
Watch us on YouTube (http://www.youtube.com/